Eli Lilly, the company developing both retatrutide and tirzepatide, is running seven TRIUMPH trials covering obesity, type 2 diabetes, and specific metabolic conditions
What Are GLP-1 Drugs and How Do They Work
While there is no single best injection site, its important to inject correctly and consistently into one of the recommended areas for optimal results, choosing the location that is most comfortable for you
GIP, GLP-1 & glucagon receptor agonist for subcutaneous injection
Axford at I24, Diamond Light Source, Oxford, UK for technical support
January 2026: Mitsubishi Tanabe Pharma enhanced development programs in oral antidiabetic therapies to improve long-term disease management outcomes